Introduced in January, the Senate version of the Physician Payments Sunshine Act is designed to stop pharmaceutical companies from exerting influence over doctors by providing lavish gifts and services. Under the legislation, companies would be required to disclose virtually all payments to physicians once a $100 aggregate is reached. Hechler and Greenberg are among many in the industry championing an exception that would exclude the reporting of imprinted items that are less than $10 each. "I think there are many people getting involved in the cause and the message is getting out," Hechler says. "We have to realize, though, that electronic letter writing isn't effective. It's phone calls and private visits that are most effective."